Trial intelligence / Profile preview

Metoprolol for left ventricular remodeling in asymptomatic aortic regurgitation

2007-000518-34Phase 4Terminated

Sponsor
Rikshospitalet
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in aortic insufficiency (AI) comparing Metoprolol CR/XL with Placebo (2 arms). Primary endpoints: Change in left ventricular end-diastolic volume, Left ventricular end-systolic volume and 1 more. Started Sep 2011; status: terminated.

02

Drugs

Cormet
03

Conditions

aortic insufficiency (AI)

Beyond the preview

Go deeper on 2007-000518-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000518-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call